Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.39574229 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.67828676 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.67828676 |
4 | positive thymic T cell selection (GO:0045059) | 5.44581066 |
5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.44026699 |
6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.27679488 |
7 | negative T cell selection (GO:0043383) | 5.14749086 |
8 | negative thymic T cell selection (GO:0045060) | 5.14438026 |
9 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.06741390 |
10 | leukocyte aggregation (GO:0070486) | 4.97018375 |
11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.89972318 |
12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.85742990 |
13 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.83628209 |
14 | response to interleukin-15 (GO:0070672) | 4.68464086 |
15 | thymic T cell selection (GO:0045061) | 4.60460275 |
16 | positive T cell selection (GO:0043368) | 4.52223594 |
17 | tolerance induction (GO:0002507) | 4.52025217 |
18 | interferon-gamma production (GO:0032609) | 4.36728607 |
19 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.36630337 |
20 | cellular response to interleukin-15 (GO:0071350) | 4.33696751 |
21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.33196787 |
22 | negative regulation of cell killing (GO:0031342) | 4.29619373 |
23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.29619373 |
24 | T cell selection (GO:0045058) | 4.21458353 |
25 | regulation of B cell differentiation (GO:0045577) | 4.08889710 |
26 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.99760796 |
27 | B cell receptor signaling pathway (GO:0050853) | 3.96381173 |
28 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.91558023 |
29 | T cell migration (GO:0072678) | 3.82960424 |
30 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.73134904 |
31 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.69367257 |
32 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.67673059 |
33 | regulation of T cell tolerance induction (GO:0002664) | 3.64906672 |
34 | positive regulation of B cell differentiation (GO:0045579) | 3.63496058 |
35 | neutrophil activation involved in immune response (GO:0002283) | 3.60053250 |
36 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.59437038 |
37 | modulation by symbiont of host immune response (GO:0052553) | 3.59437038 |
38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.59437038 |
39 | modulation by symbiont of host defense response (GO:0052031) | 3.59437038 |
40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.59437038 |
41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.59437038 |
42 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.57802933 |
43 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.56968697 |
44 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.56968697 |
45 | T cell costimulation (GO:0031295) | 3.53252532 |
46 | Peyers patch development (GO:0048541) | 3.52910825 |
47 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.52910825 |
48 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.50929693 |
49 | lymphocyte costimulation (GO:0031294) | 3.48027602 |
50 | positive regulation of isotype switching (GO:0045830) | 3.45288037 |
51 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.43770598 |
52 | macrophage activation involved in immune response (GO:0002281) | 3.43588916 |
53 | T cell receptor signaling pathway (GO:0050852) | 3.42990057 |
54 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.40665532 |
55 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.35560145 |
56 | myeloid dendritic cell activation (GO:0001773) | 3.33710054 |
57 | positive regulation of interleukin-2 production (GO:0032743) | 3.31350166 |
58 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.29116200 |
59 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.29021289 |
60 | response to peptidoglycan (GO:0032494) | 3.27912652 |
61 | detection of bacterium (GO:0016045) | 3.24101802 |
62 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.23302552 |
63 | detection of other organism (GO:0098543) | 3.20652121 |
64 | leukocyte cell-cell adhesion (GO:0007159) | 3.20596624 |
65 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.19727553 |
66 | activated T cell proliferation (GO:0050798) | 3.18506371 |
67 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.18295485 |
68 | positive regulation of granulocyte differentiation (GO:0030854) | 3.17354382 |
69 | regulation of regulatory T cell differentiation (GO:0045589) | 3.17048973 |
70 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.14826673 |
71 | NIK/NF-kappaB signaling (GO:0038061) | 3.13579771 |
72 | myeloid dendritic cell differentiation (GO:0043011) | 3.12713702 |
73 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.09565989 |
74 | regulation of antigen processing and presentation (GO:0002577) | 3.09046689 |
75 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.07756940 |
76 | negative regulation of interleukin-12 production (GO:0032695) | 3.06716665 |
77 | mature B cell differentiation (GO:0002335) | 3.05259316 |
78 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.04128821 |
79 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.02870754 |
80 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.01346410 |
81 | B cell mediated immunity (GO:0019724) | 3.01232303 |
82 | positive regulation of DNA recombination (GO:0045911) | 3.00144118 |
83 | positive regulation of tolerance induction (GO:0002645) | 2.99290645 |
84 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.98780436 |
85 | positive regulation of B cell mediated immunity (GO:0002714) | 2.98553739 |
86 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.98553739 |
87 | T cell homeostasis (GO:0043029) | 2.98246606 |
88 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.94789618 |
89 | lymphocyte homeostasis (GO:0002260) | 2.91549822 |
90 | response to protozoan (GO:0001562) | 2.91430031 |
91 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.91126122 |
92 | regulation of isotype switching (GO:0045191) | 2.89933612 |
93 | response to muramyl dipeptide (GO:0032495) | 2.89562735 |
94 | positive regulation of antigen processing and presentation (GO:0002579) | 2.88012930 |
95 | myeloid cell activation involved in immune response (GO:0002275) | 2.87954174 |
96 | regulation of response to interferon-gamma (GO:0060330) | 2.87508417 |
97 | T cell proliferation (GO:0042098) | 2.87298760 |
98 | regulation of B cell proliferation (GO:0030888) | 2.85749293 |
99 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.85721414 |
100 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.85480535 |
101 | response to type I interferon (GO:0034340) | 2.85078375 |
102 | positive regulation of type 2 immune response (GO:0002830) | 2.84762256 |
103 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.83364308 |
104 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.81730155 |
105 | mast cell activation (GO:0045576) | 2.81411562 |
106 | regulation of B cell mediated immunity (GO:0002712) | 2.81115080 |
107 | negative regulation of bone resorption (GO:0045779) | 2.81016345 |
108 | positive regulation of immunoglobulin production (GO:0002639) | 2.80189947 |
109 | regulation of tolerance induction (GO:0002643) | 2.80056764 |
110 | positive regulation of B cell activation (GO:0050871) | 2.79799599 |
111 | regulation of alpha-beta T cell differentiation (GO:0046637) | 2.79656941 |
112 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.79546288 |
113 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.79383394 |
114 | negative regulation of phagocytosis (GO:0050765) | 2.78940092 |
115 | positive regulation of T cell differentiation (GO:0045582) | 2.78749974 |
116 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.78199473 |
117 | type I interferon signaling pathway (GO:0060337) | 2.78093841 |
118 | cellular response to type I interferon (GO:0071357) | 2.78093841 |
119 | lymph node development (GO:0048535) | 2.77680532 |
120 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.77121618 |
121 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.76721871 |
122 | regulation of granulocyte differentiation (GO:0030852) | 2.76590708 |
123 | positive regulation of B cell proliferation (GO:0030890) | 2.76352515 |
124 | natural killer cell activation (GO:0030101) | 2.76276317 |
125 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.76230789 |
126 | immunoglobulin mediated immune response (GO:0016064) | 2.75592713 |
127 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.75282505 |
128 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.75282505 |
129 | germinal center formation (GO:0002467) | 2.74142224 |
130 | positive regulation of humoral immune response (GO:0002922) | 2.73927687 |
131 | defense response to protozoan (GO:0042832) | 2.73876788 |
132 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.72462251 |
133 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.71068250 |
134 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.70741623 |
135 | cellular extravasation (GO:0045123) | 2.70079860 |
136 | negative regulation of T cell mediated immunity (GO:0002710) | 2.67917194 |
137 | B cell homeostasis (GO:0001782) | 2.66086192 |
138 | regulation of interleukin-2 production (GO:0032663) | 2.65812877 |
139 | regulation of B cell activation (GO:0050864) | 2.64661123 |
140 | regulation of extracellular matrix disassembly (GO:0010715) | 2.63786448 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.43615194 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.34118151 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.71315162 |
4 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.44967048 |
5 | * MYC_22102868_ChIP-Seq_BL_Human | 3.35506545 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.35442667 |
7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.19750490 |
8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.19677041 |
9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.14926755 |
10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.97233821 |
11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.93184768 |
12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.87957073 |
13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.85364208 |
14 | MYB_26560356_Chip-Seq_TH2_Human | 2.84510828 |
15 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.83291871 |
16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.73029045 |
17 | MAF_26560356_Chip-Seq_TH1_Human | 2.67490073 |
18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.59733373 |
19 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58578826 |
20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.57511626 |
21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.56487837 |
22 | * MYB_26560356_Chip-Seq_TH1_Human | 2.46403675 |
23 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46187362 |
24 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.45118504 |
25 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.45040578 |
26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.34658546 |
27 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.30757347 |
28 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.17788333 |
29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.11574562 |
30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10107942 |
31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.04195701 |
32 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.02835086 |
33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.98864321 |
34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.97752739 |
35 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.94312574 |
36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.94155679 |
37 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93960948 |
38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79777857 |
39 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.77434641 |
40 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.76832776 |
41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.76078085 |
42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.73001804 |
43 | MAF_26560356_Chip-Seq_TH2_Human | 1.69154576 |
44 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67642715 |
45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.64646987 |
46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54906506 |
47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.54792827 |
48 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54376608 |
49 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.50649214 |
50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50014921 |
51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49941722 |
52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.47045343 |
53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44603443 |
54 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.42702613 |
55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.42450347 |
56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.40799660 |
57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37921126 |
58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37837560 |
59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.32536250 |
60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29831716 |
61 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26219335 |
62 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.20113896 |
63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19066030 |
64 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18843356 |
65 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16171379 |
66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15157549 |
67 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13112035 |
68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12633781 |
69 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11838577 |
70 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11506165 |
71 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10436445 |
72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09976964 |
73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09367010 |
74 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09348907 |
75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08006727 |
76 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06641423 |
77 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04542960 |
78 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99600954 |
79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98456081 |
80 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96862345 |
81 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96691194 |
82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96184084 |
83 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93869231 |
84 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93724612 |
85 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93164131 |
86 | P68_20966046_ChIP-Seq_HELA_Human | 0.92957325 |
87 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92842609 |
88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92811597 |
89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92607284 |
90 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92134304 |
91 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91004713 |
92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88646604 |
93 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88572025 |
94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88568120 |
95 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88249070 |
96 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87951335 |
97 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.87951322 |
98 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.87916694 |
99 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.86972864 |
100 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.85679268 |
101 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.85655014 |
102 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85555605 |
103 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.84000309 |
104 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83570861 |
105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83112934 |
106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83086715 |
107 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82428437 |
108 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82359524 |
109 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.81694907 |
110 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81393968 |
111 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.79641174 |
112 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.78491302 |
113 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.76791022 |
114 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.75383571 |
115 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.75383571 |
116 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.75303451 |
117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73833331 |
118 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.73673717 |
119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.73635355 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.81987354 |
2 | MP0003763_abnormal_thymus_physiology | 3.70864171 |
3 | MP0005671_abnormal_response_to | 3.50380955 |
4 | MP0000685_abnormal_immune_system | 3.40995804 |
5 | MP0003436_decreased_susceptibility_to | 3.25237201 |
6 | * MP0001800_abnormal_humoral_immune | 3.18574924 |
7 | * MP0001790_abnormal_immune_system | 3.10584054 |
8 | * MP0005387_immune_system_phenotype | 3.10584054 |
9 | MP0002933_joint_inflammation | 3.01219750 |
10 | MP0003303_peritoneal_inflammation | 2.92438921 |
11 | MP0005000_abnormal_immune_tolerance | 2.90958558 |
12 | * MP0002452_abnormal_antigen_presenting | 2.70296410 |
13 | * MP0002723_abnormal_immune_serum | 2.59780741 |
14 | MP0003300_gastrointestinal_ulcer | 2.59618685 |
15 | * MP0002420_abnormal_adaptive_immunity | 2.55161340 |
16 | * MP0001819_abnormal_immune_cell | 2.50882880 |
17 | MP0009785_altered_susceptibility_to | 2.45306202 |
18 | * MP0002398_abnormal_bone_marrow | 2.36393121 |
19 | MP0002396_abnormal_hematopoietic_system | 2.33177434 |
20 | MP0005025_abnormal_response_to | 2.31856630 |
21 | MP0002166_altered_tumor_susceptibility | 2.31213152 |
22 | * MP0002405_respiratory_system_inflammati | 2.26522877 |
23 | MP0002419_abnormal_innate_immunity | 2.15512835 |
24 | * MP0000716_abnormal_immune_system | 2.13202410 |
25 | MP0002148_abnormal_hypersensitivity_rea | 2.11770412 |
26 | MP0003724_increased_susceptibility_to | 2.09937176 |
27 | MP0009333_abnormal_splenocyte_physiolog | 2.04756202 |
28 | MP0010155_abnormal_intestine_physiology | 2.00539317 |
29 | MP0000689_abnormal_spleen_morphology | 1.98736021 |
30 | MP0001533_abnormal_skeleton_physiology | 1.96964301 |
31 | MP0006082_CNS_inflammation | 1.95001688 |
32 | MP0002722_abnormal_immune_system | 1.92397453 |
33 | MP0001853_heart_inflammation | 1.91276393 |
34 | MP0005451_abnormal_body_composition | 1.86235763 |
35 | MP0004947_skin_inflammation | 1.85707116 |
36 | MP0000703_abnormal_thymus_morphology | 1.84417561 |
37 | MP0002006_tumorigenesis | 1.76434749 |
38 | * MP0002429_abnormal_blood_cell | 1.75481318 |
39 | MP0005464_abnormal_platelet_physiology | 1.73604649 |
40 | MP0004510_myositis | 1.69242705 |
41 | MP0003172_abnormal_lysosome_physiology | 1.69037742 |
42 | * MP0001845_abnormal_inflammatory_respons | 1.68845078 |
43 | MP0004808_abnormal_hematopoietic_stem | 1.62558964 |
44 | * MP0001873_stomach_inflammation | 1.57892460 |
45 | MP0005058_abnormal_lysosome_morphology | 1.52876589 |
46 | MP0003866_abnormal_defecation | 1.52862578 |
47 | MP0001851_eye_inflammation | 1.30471512 |
48 | MP0005390_skeleton_phenotype | 1.27281913 |
49 | MP0002998_abnormal_bone_remodeling | 1.26783112 |
50 | MP0000858_altered_metastatic_potential | 1.19420723 |
51 | MP0003448_altered_tumor_morphology | 1.19102736 |
52 | MP0001545_abnormal_hematopoietic_system | 1.17583346 |
53 | MP0005397_hematopoietic_system_phenotyp | 1.17583346 |
54 | MP0009840_abnormal_foam_cell | 1.17386169 |
55 | MP0010352_gastrointestinal_tract_polyps | 1.15468259 |
56 | MP0008469_abnormal_protein_level | 1.15169243 |
57 | MP0000343_altered_response_to | 1.14925034 |
58 | MP0005023_abnormal_wound_healing | 1.12733991 |
59 | MP0003566_abnormal_cell_adhesion | 1.12675047 |
60 | MP0000490_abnormal_crypts_of | 1.11426185 |
61 | * MP0000465_gastrointestinal_hemorrhage | 1.10093634 |
62 | MP0005076_abnormal_cell_differentiation | 1.09799034 |
63 | MP0009278_abnormal_bone_marrow | 1.09445108 |
64 | * MP0003795_abnormal_bone_structure | 1.09362986 |
65 | MP0008004_abnormal_stomach_pH | 1.05898107 |
66 | MP0005167_abnormal_blood-brain_barrier | 1.05384243 |
67 | MP0008260_abnormal_autophagy | 1.04581515 |
68 | MP0003183_abnormal_peptide_metabolism | 1.04132540 |
69 | MP0003075_altered_response_to | 1.03621497 |
70 | MP0002254_reproductive_system_inflammat | 1.01595588 |
71 | MP0004134_abnormal_chest_morphology | 1.01593109 |
72 | MP0003279_aneurysm | 0.96659730 |
73 | MP0002138_abnormal_hepatobiliary_system | 0.93777836 |
74 | MP0006054_spinal_hemorrhage | 0.90975101 |
75 | MP0005310_abnormal_salivary_gland | 0.87587484 |
76 | MP0003656_abnormal_erythrocyte_physiolo | 0.87250996 |
77 | MP0002332_abnormal_exercise_endurance | 0.86502607 |
78 | MP0003045_fibrosis | 0.83609432 |
79 | MP0002019_abnormal_tumor_incidence | 0.82975791 |
80 | MP0003091_abnormal_cell_migration | 0.78210714 |
81 | * MP0002113_abnormal_skeleton_development | 0.77865116 |
82 | MP0001243_abnormal_dermal_layer | 0.74404264 |
83 | MP0001348_abnormal_lacrimal_gland | 0.74186598 |
84 | MP0003828_pulmonary_edema | 0.74181146 |
85 | MP0001216_abnormal_epidermal_layer | 0.73378428 |
86 | MP0005174_abnormal_tail_pigmentation | 0.72294024 |
87 | MP0009764_decreased_sensitivity_to | 0.71570028 |
88 | * MP0001663_abnormal_digestive_system | 0.70279780 |
89 | MP0000249_abnormal_blood_vessel | 0.70023557 |
90 | MP0000604_amyloidosis | 0.69709441 |
91 | MP0002282_abnormal_trachea_morphology | 0.69098231 |
92 | MP0001542_abnormal_bone_strength | 0.66899684 |
93 | MP0002877_abnormal_melanocyte_morpholog | 0.66829903 |
94 | MP0003646_muscle_fatigue | 0.66637183 |
95 | MP0002009_preneoplasia | 0.65672878 |
96 | * MP0002115_abnormal_skeleton_extremities | 0.65430077 |
97 | MP0004381_abnormal_hair_follicle | 0.64586154 |
98 | MP0009763_increased_sensitivity_to | 0.64193393 |
99 | MP0002060_abnormal_skin_morphology | 0.64044462 |
100 | MP0001879_abnormal_lymphatic_vessel | 0.63031442 |
101 | MP0003453_abnormal_keratinocyte_physiol | 0.61377963 |
102 | MP0008961_abnormal_basal_metabolism | 0.61311021 |
103 | MP0002136_abnormal_kidney_physiology | 0.60997134 |
104 | MP0005166_decreased_susceptibility_to | 0.60041797 |
105 | MP0008007_abnormal_cellular_replicative | 0.59193031 |
106 | MP0004036_abnormal_muscle_relaxation | 0.58785653 |
107 | MP0005666_abnormal_adipose_tissue | 0.58343446 |
108 | * MP0000163_abnormal_cartilage_morphology | 0.57360710 |
109 | MP0001191_abnormal_skin_condition | 0.57173788 |
110 | MP0000767_abnormal_smooth_muscle | 0.57162426 |
111 | MP0005075_abnormal_melanosome_morpholog | 0.56591920 |
112 | MP0009765_abnormal_xenobiotic_induced | 0.56540691 |
113 | MP0004130_abnormal_muscle_cell | 0.56138932 |
114 | MP0008057_abnormal_DNA_replication | 0.55614522 |
115 | MP0004883_abnormal_blood_vessel | 0.53768992 |
116 | MP0008874_decreased_physiological_sensi | 0.52189562 |
117 | MP0003705_abnormal_hypodermis_morpholog | 0.50476607 |
118 | MP0003191_abnormal_cellular_cholesterol | 0.50328480 |
119 | MP0005503_abnormal_tendon_morphology | 0.50090754 |
120 | MP0002132_abnormal_respiratory_system | 0.49866891 |
121 | * MP0005381_digestive/alimentary_phenotyp | 0.47489081 |
122 | MP0009115_abnormal_fat_cell | 0.47134800 |
123 | MP0002277_abnormal_respiratory_mucosa | 0.46364986 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Epiphyseal dysplasia (HP:0002656) | 5.27381699 |
2 | Irregular epiphyses (HP:0010582) | 4.46272589 |
3 | Small epiphyses (HP:0010585) | 4.26899782 |
4 | Recurrent bronchitis (HP:0002837) | 3.78796952 |
5 | IgM deficiency (HP:0002850) | 3.78239707 |
6 | Abnormality of macrophages (HP:0004311) | 3.75032276 |
7 | Eczematoid dermatitis (HP:0000976) | 3.72819243 |
8 | T lymphocytopenia (HP:0005403) | 3.52063157 |
9 | Abnormal tarsal ossification (HP:0008369) | 3.49135679 |
10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.44583240 |
11 | Myositis (HP:0100614) | 3.43111751 |
12 | Abnormality of T cell number (HP:0011839) | 3.39975373 |
13 | Recurrent fungal infections (HP:0002841) | 3.32643397 |
14 | Recurrent viral infections (HP:0004429) | 3.30103985 |
15 | Vitreoretinal degeneration (HP:0000655) | 3.25607500 |
16 | Increased IgM level (HP:0003496) | 3.22896693 |
17 | Prolonged bleeding time (HP:0003010) | 3.20531407 |
18 | Metaphyseal cupping (HP:0003021) | 3.20066475 |
19 | Panhypogammaglobulinemia (HP:0003139) | 3.19944776 |
20 | Chronic otitis media (HP:0000389) | 3.17296888 |
21 | Recurrent abscess formation (HP:0002722) | 3.17106728 |
22 | Abnormal foot bone ossification (HP:0010675) | 3.15801074 |
23 | Stomatitis (HP:0010280) | 3.14823631 |
24 | Nasal polyposis (HP:0100582) | 3.13948184 |
25 | Metaphyseal dysplasia (HP:0100255) | 3.09777788 |
26 | Agammaglobulinemia (HP:0004432) | 3.08425236 |
27 | Abnormality of T cells (HP:0002843) | 3.03446664 |
28 | Encephalitis (HP:0002383) | 3.02872730 |
29 | Cupped ribs (HP:0000887) | 3.02063542 |
30 | Autoimmune hemolytic anemia (HP:0001890) | 2.98274336 |
31 | Abnormality of B cell number (HP:0010975) | 2.90942532 |
32 | B lymphocytopenia (HP:0010976) | 2.90942532 |
33 | Hypoplastic ischia (HP:0003175) | 2.89327066 |
34 | Abnormality of the vertebral endplates (HP:0005106) | 2.85591839 |
35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.83369579 |
36 | Meningitis (HP:0001287) | 2.80080365 |
37 | Irregular vertebral endplates (HP:0003301) | 2.79827574 |
38 | Abnormality of the nasal mucosa (HP:0000433) | 2.79487085 |
39 | Abnormality of the fingertips (HP:0001211) | 2.79116753 |
40 | Flat acetabular roof (HP:0003180) | 2.79096906 |
41 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.76010271 |
42 | Gastrointestinal infarctions (HP:0005244) | 2.75346071 |
43 | Flattened epiphyses (HP:0003071) | 2.75063673 |
44 | Severe combined immunodeficiency (HP:0004430) | 2.71547384 |
45 | Inflammation of the large intestine (HP:0002037) | 2.69516187 |
46 | Epistaxis (HP:0000421) | 2.67927528 |
47 | Orchitis (HP:0100796) | 2.65027231 |
48 | Delayed epiphyseal ossification (HP:0002663) | 2.63844198 |
49 | Hemoptysis (HP:0002105) | 2.63289377 |
50 | Recurrent bacterial skin infections (HP:0005406) | 2.62905921 |
51 | Vasculitis (HP:0002633) | 2.62813577 |
52 | Genu varum (HP:0002970) | 2.62300068 |
53 | Retrobulbar optic neuritis (HP:0100654) | 2.62194455 |
54 | Optic neuritis (HP:0100653) | 2.62194455 |
55 | Gastrointestinal inflammation (HP:0004386) | 2.61228433 |
56 | Flat capital femoral epiphysis (HP:0003370) | 2.60978403 |
57 | Increased IgE level (HP:0003212) | 2.58968747 |
58 | Cellulitis (HP:0100658) | 2.58608086 |
59 | Lymphopenia (HP:0001888) | 2.57730860 |
60 | Abnormality of T cell physiology (HP:0011840) | 2.57633321 |
61 | Petechiae (HP:0000967) | 2.56686342 |
62 | Mild short stature (HP:0003502) | 2.55375042 |
63 | Chest pain (HP:0100749) | 2.55371085 |
64 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.54964852 |
65 | Abnormality of femoral epiphyses (HP:0006499) | 2.54964852 |
66 | Recurrent cutaneous fungal infections (HP:0011370) | 2.54643501 |
67 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.54643501 |
68 | Restrictive lung disease (HP:0002091) | 2.54603648 |
69 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.53142857 |
70 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.53142857 |
71 | Abnormality of glycolipid metabolism (HP:0010969) | 2.53142857 |
72 | Abnormality of the ischium (HP:0003174) | 2.50381233 |
73 | Gastrointestinal stroma tumor (HP:0100723) | 2.50108693 |
74 | Increased cerebral lipofuscin (HP:0011813) | 2.48991044 |
75 | Mediastinal lymphadenopathy (HP:0100721) | 2.48139378 |
76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.48094496 |
77 | Keratoconjunctivitis sicca (HP:0001097) | 2.47879057 |
78 | IgG deficiency (HP:0004315) | 2.47419877 |
79 | Combined immunodeficiency (HP:0005387) | 2.47126000 |
80 | Loss of speech (HP:0002371) | 2.44773942 |
81 | Fatigue (HP:0012378) | 2.44216462 |
82 | Spontaneous hematomas (HP:0007420) | 2.43127960 |
83 | Granulocytopenia (HP:0001913) | 2.41348303 |
84 | Colitis (HP:0002583) | 2.40908595 |
85 | Osteomyelitis (HP:0002754) | 2.40190224 |
86 | Pustule (HP:0200039) | 2.38143471 |
87 | Enlarged epiphyses (HP:0010580) | 2.37154507 |
88 | Recurrent sinusitis (HP:0011108) | 2.36843110 |
89 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.36324556 |
90 | Exercise-induced myalgia (HP:0003738) | 2.36281018 |
91 | Gingivitis (HP:0000230) | 2.35670365 |
92 | Dysostosis multiplex (HP:0000943) | 2.34408211 |
93 | Absent frontal sinuses (HP:0002688) | 2.33787884 |
94 | Thrombocytosis (HP:0001894) | 2.33048900 |
95 | Pulmonary infiltrates (HP:0002113) | 2.31828607 |
96 | Keratoconjunctivitis (HP:0001096) | 2.29885837 |
97 | Obstructive lung disease (HP:0006536) | 2.29706129 |
98 | Chronic obstructive pulmonary disease (HP:0006510) | 2.29706129 |
99 | Short femoral neck (HP:0100864) | 2.29401825 |
100 | Chronic diarrhea (HP:0002028) | 2.28826766 |
101 | Purpura (HP:0000979) | 2.28767007 |
102 | Asymmetric septal hypertrophy (HP:0001670) | 2.28285733 |
103 | Hypergammaglobulinemia (HP:0010702) | 2.26324050 |
104 | Thyroiditis (HP:0100646) | 2.25471419 |
105 | IgA deficiency (HP:0002720) | 2.24823363 |
106 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.24217834 |
107 | Arterial thrombosis (HP:0004420) | 2.23764022 |
108 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.22954344 |
109 | Increased serum ferritin (HP:0003281) | 2.22382034 |
110 | Arthropathy (HP:0003040) | 2.20530087 |
111 | Urticaria (HP:0001025) | 2.19905593 |
112 | Recurrent skin infections (HP:0001581) | 2.19713093 |
113 | Abnormality of the femoral head (HP:0003368) | 2.18283789 |
114 | Emphysema (HP:0002097) | 2.17967012 |
115 | Limited elbow extension (HP:0001377) | 2.16989539 |
116 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.16480499 |
117 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.15929795 |
118 | Absent epiphyses (HP:0010577) | 2.15929795 |
119 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.15074705 |
120 | Increased density of long bones (HP:0006392) | 2.13362015 |
121 | Verrucae (HP:0200043) | 2.13132370 |
122 | Papilloma (HP:0012740) | 2.13132370 |
123 | Joint swelling (HP:0001386) | 2.12709608 |
124 | Coxa vara (HP:0002812) | 2.11875976 |
125 | Arthralgia (HP:0002829) | 2.09464317 |
126 | Eosinophilia (HP:0001880) | 2.05854727 |
127 | Hematochezia (HP:0002573) | 2.05577701 |
128 | Autoimmune thrombocytopenia (HP:0001973) | 2.05374538 |
129 | Hypertensive crisis (HP:0100735) | 2.02963999 |
130 | Chronic sinusitis (HP:0011109) | 2.02478766 |
131 | Abnormality of eosinophils (HP:0001879) | 2.02389642 |
132 | Persistence of primary teeth (HP:0006335) | 2.02152774 |
133 | Metaphyseal irregularity (HP:0003025) | 2.01819809 |
134 | Bronchitis (HP:0012387) | 2.01796666 |
135 | Nemaline bodies (HP:0003798) | 2.01763630 |
136 | Leukocytosis (HP:0001974) | 2.01414915 |
137 | Sepsis (HP:0100806) | 2.01044972 |
138 | Hepatosplenomegaly (HP:0001433) | 2.00395350 |
139 | Muscle fiber inclusion bodies (HP:0100299) | 2.00109985 |
140 | Abnormality of the prostate (HP:0008775) | 1.95954423 |
141 | Lymphoma (HP:0002665) | 1.92663866 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 5.43705398 |
2 | TXK | 4.00757433 |
3 | PRPF4B | 2.94148804 |
4 | JAK3 | 2.80246832 |
5 | ZAP70 | 2.54744804 |
6 | STK10 | 2.50721582 |
7 | MAP3K14 | 2.44759521 |
8 | ITK | 2.42583614 |
9 | TYK2 | 2.34033970 |
10 | BTK | 2.01074613 |
11 | EEF2K | 1.99728746 |
12 | TEC | 1.98609524 |
13 | TBK1 | 1.94479041 |
14 | JAK1 | 1.92889358 |
15 | IKBKE | 1.88397720 |
16 | ERN1 | 1.87748496 |
17 | TGFBR2 | 1.80636196 |
18 | FGFR4 | 1.72209684 |
19 | IKBKB | 1.67996429 |
20 | STK24 | 1.65438692 |
21 | CSK | 1.64912847 |
22 | FGFR3 | 1.60584562 |
23 | KIT | 1.60339045 |
24 | IRAK3 | 1.60194111 |
25 | IRAK4 | 1.59859190 |
26 | MAP3K3 | 1.58165265 |
27 | TAOK2 | 1.58040623 |
28 | GRK6 | 1.55777482 |
29 | CSF1R | 1.55735897 |
30 | SYK | 1.54854432 |
31 | MAP3K10 | 1.54296191 |
32 | LCK | 1.53896106 |
33 | HCK | 1.53645592 |
34 | NLK | 1.52854993 |
35 | BLK | 1.51307543 |
36 | MST4 | 1.49808551 |
37 | LRRK2 | 1.38968871 |
38 | MAP2K3 | 1.37378585 |
39 | CHUK | 1.27942147 |
40 | SMG1 | 1.25539266 |
41 | PIM1 | 1.22464332 |
42 | TRIB3 | 1.21641697 |
43 | PIM2 | 1.20424067 |
44 | EPHB1 | 1.20155161 |
45 | KDR | 1.17178485 |
46 | RPS6KA4 | 1.14904716 |
47 | CLK1 | 1.09993209 |
48 | MAP3K1 | 1.08779795 |
49 | NME2 | 1.07887651 |
50 | CDK12 | 1.07731151 |
51 | LYN | 1.00827687 |
52 | PKN2 | 1.00466231 |
53 | MARK3 | 0.95766291 |
54 | SIK3 | 0.94197592 |
55 | FES | 0.92837736 |
56 | TRPM7 | 0.92820487 |
57 | SIK2 | 0.90853280 |
58 | CDC42BPA | 0.88903392 |
59 | MARK2 | 0.88749806 |
60 | PRKCQ | 0.87414654 |
61 | MAP3K13 | 0.86062626 |
62 | TGFBR1 | 0.86001702 |
63 | BMPR2 | 0.82468002 |
64 | MATK | 0.82043102 |
65 | EPHA3 | 0.80496543 |
66 | FGR | 0.79605284 |
67 | PIK3CG | 0.78381045 |
68 | OBSCN | 0.75876185 |
69 | FLT3 | 0.75644346 |
70 | JAK2 | 0.75434610 |
71 | TTN | 0.74329043 |
72 | TAOK1 | 0.73610783 |
73 | PRKCH | 0.73278789 |
74 | IRAK2 | 0.72237741 |
75 | TAOK3 | 0.70691744 |
76 | SIK1 | 0.68795023 |
77 | PTK6 | 0.67645130 |
78 | CDK9 | 0.63414114 |
79 | RPS6KL1 | 0.62058747 |
80 | RPS6KC1 | 0.62058747 |
81 | MAP3K7 | 0.60800040 |
82 | PRKG2 | 0.59832232 |
83 | NEK9 | 0.59174462 |
84 | RIPK4 | 0.57259467 |
85 | TNK2 | 0.55555347 |
86 | RPS6KA6 | 0.55381902 |
87 | CDK4 | 0.55336347 |
88 | HIPK2 | 0.53541126 |
89 | MOS | 0.53159155 |
90 | KSR2 | 0.52749367 |
91 | CCNB1 | 0.52440462 |
92 | ICK | 0.51752786 |
93 | BRD4 | 0.51682482 |
94 | RIPK1 | 0.51636248 |
95 | CDK6 | 0.50492320 |
96 | MAPK7 | 0.49120735 |
97 | MAPK12 | 0.48810445 |
98 | PDGFRB | 0.48216434 |
99 | NUAK1 | 0.47906186 |
100 | MAP2K2 | 0.47534023 |
101 | DMPK | 0.45693400 |
102 | ABL1 | 0.45644744 |
103 | MAPK4 | 0.44335507 |
104 | TIE1 | 0.43809589 |
105 | MAPKAPK2 | 0.42809477 |
106 | MAP3K11 | 0.42062853 |
107 | GRK7 | 0.41555405 |
108 | PDPK1 | 0.41553757 |
109 | MAP2K6 | 0.40656638 |
110 | PDK1 | 0.39510352 |
111 | MELK | 0.38503457 |
112 | TESK2 | 0.36826354 |
113 | SGK3 | 0.36756017 |
114 | STK3 | 0.36205430 |
115 | TYRO3 | 0.36155741 |
116 | EGFR | 0.34311881 |
117 | IGF1R | 0.33561858 |
118 | EIF2AK3 | 0.32923100 |
119 | INSR | 0.32850196 |
120 | STK4 | 0.32544769 |
121 | CAMKK1 | 0.32148912 |
122 | MAPK11 | 0.30514141 |
123 | PASK | 0.30395638 |
124 | MAPKAPK3 | 0.30330137 |
125 | MAP3K8 | 0.30032176 |
126 | PRKD2 | 0.28432378 |
127 | RPS6KB2 | 0.28337987 |
128 | * MAPK3 | 0.26936365 |
129 | IRAK1 | 0.25930046 |
130 | TSSK6 | 0.25889357 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.38252304 |
2 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.79921421 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.74258679 |
4 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.66187632 |
5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.62295077 |
6 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.56145187 |
7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.52093349 |
8 | Measles_Homo sapiens_hsa05162 | 2.45988839 |
9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.28835480 |
10 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25416025 |
11 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.17633015 |
12 | Allograft rejection_Homo sapiens_hsa05330 | 2.17163220 |
13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.14896973 |
14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.84896612 |
15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.82403843 |
16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.81949392 |
17 | Malaria_Homo sapiens_hsa05144 | 1.75183723 |
18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.64998805 |
19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.61859722 |
20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.60770167 |
21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.55070103 |
22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.52146752 |
23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.50181869 |
24 | Legionellosis_Homo sapiens_hsa05134 | 1.46883026 |
25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.44191968 |
26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.41799856 |
27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.40790263 |
28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.39535484 |
29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.38047887 |
30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.35793987 |
31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34527316 |
32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.33677375 |
33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30540153 |
34 | * Hepatitis B_Homo sapiens_hsa05161 | 1.30506046 |
35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29172212 |
36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28949808 |
37 | Asthma_Homo sapiens_hsa05310 | 1.28291531 |
38 | Shigellosis_Homo sapiens_hsa05131 | 1.28071773 |
39 | Apoptosis_Homo sapiens_hsa04210 | 1.27090039 |
40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.25096629 |
41 | Influenza A_Homo sapiens_hsa05164 | 1.23713559 |
42 | Tuberculosis_Homo sapiens_hsa05152 | 1.19346494 |
43 | Pertussis_Homo sapiens_hsa05133 | 1.14140352 |
44 | Platelet activation_Homo sapiens_hsa04611 | 1.11492861 |
45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06250451 |
46 | * HTLV-I infection_Homo sapiens_hsa05166 | 1.03264050 |
47 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02856944 |
48 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.00221426 |
49 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99546698 |
50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.95602833 |
51 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.89529088 |
52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87956436 |
53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.87349723 |
54 | Salmonella infection_Homo sapiens_hsa05132 | 0.86297871 |
55 | Ribosome_Homo sapiens_hsa03010 | 0.84367864 |
56 | Hepatitis C_Homo sapiens_hsa05160 | 0.83505119 |
57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.82910825 |
58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80148596 |
59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78540220 |
60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77471619 |
61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73547921 |
62 | Phagosome_Homo sapiens_hsa04145 | 0.72696286 |
63 | Focal adhesion_Homo sapiens_hsa04510 | 0.66619098 |
64 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.65838862 |
65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65820676 |
66 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65032761 |
67 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64250717 |
68 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60956056 |
69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60352002 |
70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56025862 |
71 | Insulin resistance_Homo sapiens_hsa04931 | 0.55515272 |
72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55433602 |
73 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54045853 |
74 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53955700 |
75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53900577 |
76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52651815 |
77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50666137 |
78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50539811 |
79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48002136 |
80 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.47744129 |
81 | Adherens junction_Homo sapiens_hsa04520 | 0.47682636 |
82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47600380 |
83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44420163 |
84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43957677 |
85 | Bladder cancer_Homo sapiens_hsa05219 | 0.43837852 |
86 | Prostate cancer_Homo sapiens_hsa05215 | 0.43578994 |
87 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.43282807 |
88 | Base excision repair_Homo sapiens_hsa03410 | 0.41910378 |
89 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.41839761 |
90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41778804 |
91 | Prion diseases_Homo sapiens_hsa05020 | 0.41636776 |
92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41312675 |
93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40816275 |
94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40388552 |
95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39665906 |
96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39265703 |
97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38419922 |
98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38088492 |
99 | Amoebiasis_Homo sapiens_hsa05146 | 0.37444168 |
100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.37258936 |
101 | Endocytosis_Homo sapiens_hsa04144 | 0.36641149 |
102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36569366 |
103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36545575 |
104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36360277 |
105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35156953 |
106 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.35002395 |
107 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34996938 |
108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33696202 |
109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33200628 |
110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30360173 |
111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29047394 |
112 | Lysine degradation_Homo sapiens_hsa00310 | 0.28765222 |
113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28297498 |
114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27114866 |
115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.26521574 |
116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25151053 |
117 | Lysosome_Homo sapiens_hsa04142 | 0.25150150 |
118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24694270 |
119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24249590 |
120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22664087 |
121 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.22326857 |
122 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.21691392 |
123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.20787823 |